Shire Patent Suit Dismissal Will Delay Generic: Alkem
Alkem Laboratories Ltd. on Tuesday moved to block Shire Canada Inc.'s voluntary dismissal of its Illinois suit accusing the drugmaker of infringing its patents for kidney failure treatment Fosrenol, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article